The 'Wearing Off' Effect of DMT

NCT05627271 · clinicaltrials.gov ↗

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis

Interventions

OTHER: ocrelizumab
OTHER: natalizumab
OTHER: ofatumumab

Sponsor

Novartis Pharmaceuticals